cheqfx
Advertisement · 728×90
‹ All stocks
DERM

Journey Medical

DERM · NASDAQ · Healthcare
$6.66
▼ $6.66 (-0.60%)
$6.24 $6.44 $6.64 $6.84 $6.66 Sep 28 Oct 01 Oct 04
Day range
$6.47 – $6.76
Year range
$4.31 – $9.56
Open
$6.70
Previous close
—
Market cap
$183.29M
Volume (24h)
$84.5K
Volume (52w)
$563.08K
Performance
7D
▲ 3.58%
1M
▼ -14.29%
3M
▼ -7.76%
6M
▲ 37.04%
1Y
▼ -8.77%
YTD
▼ -10.60%
3Y
▲ 146.67%
5Y
▼ -29.89%
All-time
▼ -29.89%
Key statistics
P/E ratio
-30.27
EPS (TTM)
$-0.22
Dividend yield
—
Dividend (TTM)
—
Payout ratio
—
Shares outstanding
27.5M
About Journey Medical

Journey Medical Corporation, a pharmaceutical firm established in Scottsdale, Arizona in 2014 (and previously known as Coronado Dermatology, Inc.), is dedicated to the development and market introduction of treatments for skin conditions across the United States. Their product line encompasses key dermatological therapies such as Qbrexza, a medicated cloth wipe for managing primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug for severe, persistent acne; Targadox, an oral doxycycline medication used as an additional treatment for severe acne; Ximino, an oral minocycline drug addressing moderate to severe acne; and Exelderm, offered as a topical cream and solution. Furthermore, the company distributes doxycycline hyclate tablets, minocycline hydrochloride capsules, and sulconazole nitrate cream and solution.

Visit website
Country: United States of America
More in Healthcare